AAPS PharmSciTech

عنوان


AAPS PharmSciTech


ژورنال مديليب منبع معتبر تحقيقات و پژوهش ها در زمينه پزشکي ميباشد.فلسفه ژورنال‌ها، حفظ و نگهداري مطالب علمي و ثبت به نام صاحب اثر و جلوگيري از سرقت ادبي است

AAPS PharmSciTech, an official journal of the American Association of Pharmaceutical Scientists, publishes papers that focus on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems. Innovative in its content and practices, AAPS PharmSciTech, an online-only journal, uses technologically-driven tools and methods by which the scientific community can more efficiently disseminate their research.  

The premier journals of the American Association of Pharmaceutical Scientists have established a position of leadership among pharmaceutical scientists and successfully disseminate expert, high-quality content to the pharmaceutical sciences community.

AAPS PharmSciTech produces papers that focus on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems. Innovative in its content and practices, the journal uses technologically-driven tools and methods through which the scientific community can more efficiently disseminate their research.

There are several notable features for AAPS PharmSciTech:
 

  • Has an 89% overall satisfaction score from Springer Nature surveys
  • Administers fast peer review:
    • Less than 1 day from submission to editor review     
    • Average first decision time is 30 days for manuscripts selected for peer review
    • Average time from submission to final decision is 89 days (includes time for revisions)
    • Response to inquiries within one business day, and direct access to the Editor-in-Chief 
  • Distinguished teams of international Editors and Editorial Advisory Board
  • International readership with nearly 500,000 downloads per year
  • Accepted manuscripts are published online within an average of 30 days (includes time for proof approval by authors)
  • Uses the continuous publishing model, so articles can be cited immediately upon publication
  • Full-text articles available at more than 8,000 institutions worldwide
  • Does not levy submission or publication charges (unless author chooses Open Choice)
  • Free color publication and supplemental files, including video

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟